AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπΌ
ATORVASTATIN in Zimbabwe
1 product registered with MCAZ β 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ATORSTATIN 20 TABLET, COATED; ORAL | 2021/12.8/6193 | COSPHARM INVESTMENTS (PTY) LTD | active | 31 Dec 2027 |
ATORVASTATIN β MCAZ Registration Details
MCAZ (Zimbabwe) has 1 registered product containing ATORVASTATIN, of which 1 is currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track ATORVASTATIN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.